Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
Arjen Joosse(Erasmus MC), Jutta Engel(Universidad de Granada), Esther de Vries(Tilburg University), J.W.W. Coebergh(Erasmus University Rotterdam), Renate Eckel(Ludwig-Maximilians-Universität München), Alexander M.M. Eggermont(University Medical Center Utrecht), D. Hölzel(Ludwig-Maximilians-Universität München), Tamar Nijsten(Erasmus MC)
Cited by 265
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k